Dec 13 (Reuters) - Swedish Orphan Biovitrum AB (publ) SOBIV.ST:
SOBI TO ACQUIRE ARTHROSI THERAPEUTICS, STRENGTHENING PIPELINE FOR THE POTENTIAL TREATMENT OF GOUT
SWEDISH ORPHAN BIOVITRUM - SOBI TO PAY $950 MILLION UPFRONT FOR ARTHROSI
SWEDISH ORPHAN BIOVITRUM - ACQUISITION EXPECTED TO BE HIGHLY ACCRETIVE TO SOBI'S MID- TO LONG-TERM GROWTH AND MARGIN TRAJECTORY
SWEDISH ORPHAN BIOVITRUM - SOBI TO PAY UP TO $550 MILLION IN MILESTONES
Source text: ID:nWkr8hWRtK
Further company coverage: SOBIV.ST
((Reuters.Briefs@thomsonreuters.com;))